Affimed
AFMD
#10502
Rank
NZ$4.94 M
Marketcap
NZ$0.30
Share price
0.00%
Change (1 day)
-83.38%
Change (1 year)

Market capitalization of Affimed (AFMD)

Market cap: NZ$4.94 Million

As of February 2026 Affimed has a market cap of NZ$4.94 Million. This makes Affimed the world's 10502th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Affimed from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.94 M-3.84%
2025NZ$5.13 M-86.3%
2024NZ$37.49 M-74.6%
2023NZ$0.14 B-49.4%
2022NZ$0.29 B-69.87%
2021NZ$0.96 B22.33%
2020NZ$0.79 B155.12%
2019NZ$0.31 B7.17%
2018NZ$0.28 B253.99%
2017NZ$81.76 M-5.39%
2016NZ$86.42 M-75.02%
2015NZ$0.34 B82.31%
2014NZ$0.18 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Affimed was reported to be:

NZ$4.58 Million
by Nasdaq info icon info icon
NZ$4.94 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
NZ$13.96 B 282,507.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$0.37 B 7,420.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.17 B 3,349.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.36 M-72.40%๐Ÿ‡บ๐Ÿ‡ธ USA